UBS Lux Equity Fund Biotech USD vs DNB Aktiv 80 A
1. UBS Lux Equity Fund Biotech USD
2. DNB Aktiv 80 A
-
Security
DNB Aktiv 80 A
-
Fee
1.04%
-
ISIN
NO0010337793
-
Holdings
1
Fund Holdings
We have information about 14 holdings in UBS Lux Equity Fund Biotech USD, where the largest holding is Regeneron Pharmaceuticals (10.04), followed by Vertex (9.35) and Moderna (9.21). In comparison with DNB Aktiv 80 A, we have 1 holdings where DNB Teknologi is the largest holding (11.16), followed by (0) and (0).
All Holdings
Here we compare the holdings in UBS Lux Equity Fund Biotech USD and DNB Aktiv 80 A.
UBS Lux Equity Fund Biotech USD |
DNB Aktiv 80 A |
1. Regeneron Pharmaceuticals Inc 10.04 % |
1. DNB Teknologi A 11.16 % |
2. Vertex Pharmaceuticals Inc 9.35 % |
- |
3. Moderna Inc 9.21 % |
- |
4. Alnylam Pharmaceuticals Inc 6.96 % |
- |
5. AbbVie Inc  5.53 % |
- |
6. Gilead Sciences Inc  4.66 % |
- |
7. Amgen Inc 4.3 % |
- |
8. BioNTech SE 4.13 % |
- |
9. Karuna Therapeutics Inc 3.75 % |
- |
10. Royalty Pharma Plc 3.37 % |
- |
The list of fund holdings was last updated on June 5, 2025.